Meet our leadership.
Rich Yang
CEO
25 years of experience in the metabolic health sector. Product management and strategy for glucose sensing. Rich previously held management positions at Dexcom and Medtronic. He was named inventor in dozens of patents. Rich received his B.S. degree in Biological Sciences from the University of California, Irvine.
Jared Tangney, PhD
President & COO
Biolinq Co-founder with a decade of experience in micro-array sensor research & development. Jared received his Ph.D. in Bioengineering from the University of California, San Diego, and was a Business Technology Fellow at the University of California, San Diego Jacobs School of Engineering.
Joel Goldsmith
VP, Product Strategy
Over 20 years of experience in MedTech product management. Expert in biowearables and digital health. Previously held product management and strategy roles at Abbott, Medtronic, Baxter, and IBM. Joel holds a B.A. in Neuroscience from the University of Pennsylvania, received his MBA from UCLA Anderson School of Management, and was a Biodesign Fellow at Stanford University.
Amy Vandenberg
VP, Regulatory & Clinical Affairs
Accomplished regulatory & clinical development expert with 25 years of experience across multiple therapeutic areas in Diabetes and Obesity. Former Chief Officer of QA, Clinical & Regulatory at Obalon and Director, Regulatory at Dexcom. Amy received her B.S. degree in Biology from Saint Mary’s College of California.
Mark Brister
VP, R&D
Over 38 years in pioneering medical device technologies with over 100 products launched and more than 300 patents issued as a prolific Medtech inventor. Former VP of R&D leadership roles at Guidant Corp., Arterial Vascular Engineering, Medtronic, Dexcom, and Obalon.
Naresh Bhavaraj, PhD
VP, Data
Over 20 years of experience in medical device R&D, advanced algorithm and systems design, data science, software development, and mobile medical applications. Former VP of engineering & technology at Medtech startup, R&D, and algorithm & systems director at Dexcom. Naresh received his Ph.D. in Biomedical Engineering from the University of Texas at Austin.
Rebecca Gottlieb, PhD
VP, Advanced Technologies
Over 20 years of experience in glucose sensor R&D and advanced technologies, including closed-loop algorithms, analyte sensing, drug delivery, and consumer and hospital-based technologies. Former VP of Research & Technology at Medtronic Diabetes. Rebecca received her Ph.D. in Bioengineering from the University of Pittsburgh.
Drew Woodmansee
VP, Legal Affairs & Head of IP
Accomplished IP litigation attorney with 25 years in private practice at global law firms advising clients in the medical device, pharmaceutical, and medical diagnostics sectors. Former Partner at Jones Day and Morrison & Foerster. Drew received his B.A. from the University of Notre Dame and his J.D. from Notre Dame Law School.
Brian Kelly, MD
VP, Corporate Development
20 years as a neurologist & intensive care specialist with the US Navy. Decades of experience in informatics and strategic partnerships with global technology leaders in healthcare. Previous President, Payer, and Provider Solutions at IQVIA, Former Head of Informatics, and National Medical Director at Aetna; Executive Partner at Accenture.
David Carner
VP, Quality
30 years of management experience at medical device companies specializing in cardiometabolic health in the role of quality assurance and R&D. Former VP of Quality at Dexcom and held leadership roles at Abbott Vascular, Guidant, St. Jude Medical, Pacesetter. David received his B.S. degree in Aerospace Engineering from the University of Texas at Arlington.
Kate Hunter
Director, Regulatory Affairs
More than 15 years in Regulatory Affairs, managing multiple PMA approvals, 510(k) clearances, and De Novo classification grants, and 12 years of CGM experience from her previous role at Dexcom. Kate holds B.S. and B.A. degrees from SDSU and Florida State University and received her J.D. from the University of San Diego School of Law.
